Therapeutics: Factor VIII; CRISPR-associated protein 9 (Cas9)

In vitro and mouse studies suggest gene-edited pluripotent stem (iPS) cells could help treat hemophilia A by restoring Factor VIII expression. In iPS cells derived from two hemophilia patients with di...